Vaxart, Inc. Increase (Decrease) in Receivables
Vaxart, Inc. (VXRT) reported Increase (Decrease) in Receivables of -$996.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2012-11-08
- Vaxart, Inc. increase (decrease) in receivables for the quarter ending 2012-09-30 was -$1.00K, a 100.61% decline year-over-year.
- Vaxart, Inc. increase (decrease) in receivables for the quarter ending 2012-06-30 was -$128.00K.
- Vaxart, Inc. increase (decrease) in receivables for the quarter ending 2012-03-31 was -$867.00K, a 115.91% decline year-over-year.
- Vaxart, Inc. increase (decrease) in receivables for the quarter ending 2011-12-31 was $104.00K.
- Vaxart, Inc. increase (decrease) in receivables for fiscal 2011 was -$35.00K.
- Vaxart, Inc. increase (decrease) in receivables for fiscal 2010 was -$8.09M, a 221.06% decline from fiscal 2009.
- Vaxart, Inc. increase (decrease) in receivables for fiscal 2009 was $6.68M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$129.00K derived: sum of 2 quarters · filed 2012-11-08 | -$996.00K 10-Q · filed 2012-11-08 | -$892.00K derived: sum of 4 quarters · filed 2012-11-08 |
| 2012-06-30 | -$128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$995.00K 10-Q · filed 2012-08-09 | -$891.00K derived: sum of 3 quarters · filed 2012-08-09 | -$726.00K derived: sum of 4 quarters · filed 2012-08-09 |
| 2012-03-31 | -$867.00K 10-Q · filed 2012-05-10 | -$763.00K derived: sum of 2 quarters · filed 2012-05-10 | -$598.00K derived: sum of 3 quarters · filed 2012-05-10 | -$6.35M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $269.00K derived: sum of 2 quarters · filed 2012-03-14 | -$5.49M derived: sum of 3 quarters · filed 2012-08-09 | -$35.00K 10-K · filed 2012-03-14 |
| 2011-09-24 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$5.59M derived: sum of 2 quarters · filed 2012-08-09 | -$139.00K 10-Q · filed 2012-11-08 | -$3.10M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-06-25 | -$5.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$304.00K 10-Q · filed 2012-08-09 | -$3.26M derived: sum of 3 quarters · filed 2012-08-09 | -$3.86M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-26 | $5.45M 10-Q · filed 2012-05-10 | $2.49M derived: sum of 2 quarters · filed 2012-05-10 | $1.90M derived: sum of 3 quarters · filed 2012-05-10 | |
| 2010-12-25 | -$2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$3.56M derived: sum of 2 quarters · filed 2012-03-14 | -$8.09M 10-K · filed 2012-03-14 | |
| 2010-09-25 | -$597.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$5.13M 10-Q · filed 2011-11-02 | ||
| 2010-06-26 | -$4.54M 10-Q · filed 2011-08-03 | |||
| 2009-12-26 | $6.68M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |